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Blood Leukocyte mRNA Expression for IL-10, IL-1Ra, and
IL-8, but Not IL-6, Increases After Exercise
DAVID C. NIEMAN,1 DRU A. HENSON,1 J. MARK DAVIS,2 CHARLES L. DUMKE,1
ALAN C. UTTER,1 E. ANGELA MURPHY,2 STEVEN PEARCE,1 GREG GOJANOVICH,1
STEVEN R. MCANULTY,1 and LISA S. MCANULTY1

ABSTRACT
The primary purpose of this project was to study exercise-induced leukocyte cytokine mRNA expression.
Changes in plasma cytokine levels and blood leukocyte mRNA expression for interleukin-6 (IL-6), IL-8, IL10, and IL-1 receptor antagonist (IL-1Ra) were measured in 12 athletes following 2 h of intensive cycling
(64% Wattsmax) while ingesting a carbohydrate or placebo beverage (randomized and double blinded). Blood
samples were collected 30 min preexercise and immediately and 1 h postexercise. Carbohydate compared with
placebo ingestion attenuated exercise-induced changes in plasma cortisol (8.8% vs. 62%, respectively), epinephrine (9.2% vs. 138%), IL-6 (10-fold vs. 40-fold), IL-10 (8.9-fold vs. 26-fold, and IL-1Ra (2.1-fold vs.
5.6-fold). Significant time effects were measured for blood leukocyte IL-8 (2.4-fold increase 1 h postexercise),
IL-10 (2.7-fold increase), IL-1Ra (2.2-fold increase), and IL-6 (0.8-fold decrease) mRNA content, with no significant differences between Cho and Pla test conditions. In summary, gene expression for IL-8, IL-10, and
IL-1Ra, but not IL-6, is increased in blood leukocytes taken from athletes following 2 h of intensive cycling
and is not influenced by carbohydrate compared with placebo ingestion. mRNA expression was high enough
to indicate a substantial contribution of blood leukocytes to plasma levels of IL-8, IL-10, and IL-1Ra during
prolonged exercise.

INTRODUCTION

A

concentrations of several
cytokines, including interleukin-6 (IL-6), IL-10, IL-8, IL1 receptor antagonist (IL-1Ra), granulocyte colony-stimulating
factor (G-CSF), monocyte chemoattractant protein-1 (MCP-1),
and macrophage inflammatory protein-1  (MIP-1), occurs in
response to prolonged and intensive exercise.1–7 Sources of production of these cytokines are still being explored.
After heavy exercise workloads, the mRNA content for tumor
necrosis factor- (TNF-), IL-8, IL-1, and IL-6 within muscle
biopsy samples is increased, with the greatest fold increases measured for IL-6 and IL-8 mRNA (20–30-fold change from rest
when rest1).2,3,8–12 Although muscle cells produce most of the
IL-6 during exercise,11–13 production of other cytokines within
muscle biopsy samples may come from several types of cells.
Blood mononuclear cells do not appear to contribute IL-1, TNF, or IL-6 during sustained exercise.10,14 In a previous study, we
MARKED INCREASE IN THE PLASMA

noted that IL-8 mRNA expression was highest in postexercise
muscle biopsy samples that visually appeared to have the most
blood.2 IL-8 is produced by a variety of cells throughout the body,
including endothelial cells and blood mononuclear cells,15 but the
primary source during exercise is unknown. Recently, Akerstrom
et al.16 showed that IL-8 protein expression occurred within the
cytoplasm of muscle fibers following 3 h of bicycle exercise but
could not rule out contributions from other cell types, including
endothelial cells and leukocytes. The anti-inflammatory cytokines
IL-10 and IL-1Ra are derived from a variety of cell sources, including blood monocytes, but sources of production during exercise have not yet been determined. Ostrowski et al.10 proposed
that exercise triggers IL-6 production within muscle cells, leading to a stimulation of IL-1Ra release from circulating blood
mononuclear cells. Steensberg et al.17 showed that infusion of recombinant human IL-6 (rHuIL-6) increased plasma IL-1Ra and
IL-10 levels compared with saline infusion but did not identify
the sources of production.

1Departments of Health, Leisure, and Exercise Science, Biology, Family and Consumer Sciences, Fischer Hamilton/Nycom Biochemistry Laboratory, Appalachian State University, Boone, NC 28608.
2Department of Exercise Science, University of South Carolina, Columbia, SC 29208.

668

EXERCISE AND BLOOD CYTOKINE mRNA
In multiple studies, we and others have shown that carbohydrate compared with placebo ingestion attenuates exerciseinduced increases in blood neutrophils, monocyte, T, and natural killer (NK) cell counts, plasma cortisol, epinephrine, IL-6,
IL-10, and IL-1Ra, but not IL-8.1–3,5,6,9,18–26 Carbohydrate may
exert these effects through multiple mechanisms, including elevation in blood glucose and tissue glucose uptake, decreases
in cytokine mRNA expression, reductions in proinflammatory
signals, and an attenuation of IL-6 release from the working
muscle tissue.1,3,6,17,19 Carbohydrate ingestion during prolonged exercise permits investigation of the relative importance
of these stimuli under randomized, placebo-controlled conditions.
The purpose of this project was to study the effect of carbohydrate compared with placebo ingestion on plasma hormone
and cytokine levels and leukocyte cytokine mRNA expression
following 2 h of intensive cycling. We hypothesized that carbohydrate compared with placebo ingestion would attenuate
plasma hormone and cytokine levels after exercise. Based on
limited information, we also hypothesized that blood leukocyte
mRNA for IL-10, IL-8, IL-1Ra, but not IL-6, would increase
during exercise, but not to the same magnitude during the carbohydrate trials. The cytokines measured in this study are based
on prior studies showing that of plasma cytokines measured to
date by exercise immunologists, IL-6, IL-8, IL-10, and IL-1Ra
are among those that increase most during exercise.1–7 We and
other investigators have shown little or no exercise-induced
increases for IL-2, IL-3, IL-4, IL-12, interferon- (IFN-),
TNF-, and IL-1.5,7

MATERIALS AND METHODS
Subjects
Twelve trained male cyclists were recruited as experimental
subjects through local and collegiate cycling clubs. Written informed consent was obtained from each subject, and the experimental procedures were approved by the university institutional review board.

Research design
Two to three weeks prior to the first test session, subjects reported to the ASU Human Performance Laboratory for orientation and measurement of body composition and cardiorespiratory fitness. Body composition was assessed by hydrostatic
weighing using an electronic load cell system (Exertech, Dresbach, MN), estimated residual volume, and the Siri equation.27
VO2max was determined using a graded maximal protocol (25
W increase every 2 min starting at 150 W) with the subjects
using their own bicycles on CompuTrainer Pro Model 8001
trainers (RaceMate, Seattle, WA). Oxygen uptake and ventilation were measured using the MedGraphics CPX metabolic system (MedGraphics Corporation, St. Paul, MN). Heart rate was
measured using a chest heart rate monitor (Polar Electro Inc.,
Woodbury, NY). Basic demographic and training data were obtained through a questionnaire.
Subjects agreed to avoid the use of large-dose vitamin/mineral
supplements (100% of recommended dietary allowances), nutritional supplements, ergogenic aids, herbs, and medications
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known to affect immune function for 1 week prior to test sessions.
During orientation, a dietitian instructed the subjects to follow a
diet moderate in carbohydrate during the 3 days prior to the test
session and record intake in a food record. The food records were
analyzed using a computerized dietary assessment program (Food
Processor, ESHA Research, Salem, OR).
On test session dates, a standardized liquid meal (Boost Plus,
Mead Johnson Nutritionals, Evansville, IN) was ingested at an
energy level of 67 kJ  kg1 (16 kcal  kg1) body mass by subjects prior to 10:00 AM. Boost Plus is a nutritionally complete,
high-energy oral supplement with an energy density of 6.4
kJ  ml1 (1.52 kcal  ml1) and contains 16% of energy as protein, 34% as fat, and 50% as carbohydrate. In quantities of 1000
mL, Boost Plus exceeds daily value recommendations for all
major vitamins and minerals.
Subjects came to the laboratory for two 2-h test sessions and
ingested carbohydrate or placebo beverages in a randomized,
counterbalanced design. The test sessions were 1–2 weeks apart.
Subjects cycled for 2.0 h at 60%–65% Wattsmax. On test session dates, subjects reported to the laboratory at 3:00 PM, not
having ingested energy in any form after 10:00 AM. Blood samples were collected 30 min preexercise, immediately postexercise, and 1 h postexercise. Blood samples were drawn from
an antecubital vein with subjects in the seated position. Experimental subjects ingested carbohydrate (6% or 60 g  l1) or
placebo beverages 15–30 min preexercise (12 ml  kg1) and
during the 2-h cycling bout (4 ml  kg1  15 min1). The beverages were supplied by the Gatorade Sports Science Institute
(Barrington, IL). The carbohydrate and placebo beverages were
identical in appearance and taste and in sodium (19.0
mEq  l1) and potassium (3.0 mEq  l1) concentration and
pH (3.0). No other beverages or food were ingested during
the test sessions.
During the test sessions, subjects cycled using their own bicycles on trainers (CompuTrainer Pro Model 8001) with the exercise load set at 60%–65% maximal Watts and 75%
VO2max. Metabolic measurements were made every 30 min of
cycling using the MedGraphics CPX metabolic system to verify workload.

Leukocyte mRNA extraction and cDNA synthesis
The QIAampRNA Blood Mini Kit Protocol (Qiagen, Valencia CA) was used to extract mRNA. From each subject, two
1.5-mL aliquots of whole blood collected in EDTA were puri-

TABLE 1. SUBJECT CHARACTERISTICS
OF MALE CYCLISTS (n  12)
Variable

Value

Age (years)
Height (m)
Body mass (kg)
Body composition (% fat)
Heart rate, maximal (beatsmin1)
Powermax (W)
VO2max (ml kg1 min1)
Minute ventilation, maximal (lmin1)
aMean

 SE.

21.0
1.78
71.6
11.9
191
335
56.9
166










1.0a
0.01
1.9
1.0
2
8
1.3
6
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TABLE 2.

PLASMA GLUCOSE, INSULIN, CORTISOL, AND EPINEPHRINE IN 12 CYCLISTS UNDER CARBOHYDRATE (C)
AND PLACEBO (P) CONDITIONS BEFORE AND AFTER 2 H OF INTENSIVE CYCLING

Variable
Glucose (mmolL1)
C
P
Insulin (pmol L1)
C
P
Cortisol (mmolL1)
C
P
Epinephrine (pmol L1)
C
P

Preexercise

Postexercise

1 h postexercise

p value:
interactionsa

5.52  0.13
5.38  0.15

6.46  0.36*
5.05  0.21

6.15  0.43
4.90  0.11

0.004; 0.510

122  40.4
76.8  17.5

226  51.9
97.5  21.4

249  51.5*
27.7  6.28

0.050; 0.097

319  31
303  30

347  52*
490  45

263  42*
434  51

0.001; 0.042

808  140
732  90

734  120
1740  580

638  130
771  110

0.049; 0.022

aInteraction: The first p value represents the condition (carbohydrate vs. placebo)  time (3 time points) interaction; the second p value represents the overall time effect.
*Significant difference in change from preexercise in carbohydrate compared with placebo trials, p  0.05.

fied for RNA. Briefly, erythrocytes were selectively lysed, and
leukocytes were recovered by centrifugation. Samples were
briefly centrifuged through a QIAshredder spin column, ethanol was added to adjust binding conditions, and the sample was
applied to a QIAamp spin column. RNA was bound to the silica gel membrane during a brief centrifugation step. Contaminants were washed away, and total RNA was eluted in 30 L
of RNase-free water.
The extracted RNA (7.5 L of sample) was dissolved in diethylpyrocarbonate-treated water and quantified spectrophotometrically at 260-nm wavelength. RNA was reverse transcribed
into cDNA in a 50-L reaction volume containing 19.25 l
RNA in RNase-free water, 5 L 10 RT buffer, 11 L 25 mM
MgCl2, 10 L deoxyNTPs mixture, 2.5 L random hexamers,
1 L RNase inhibitor, and 1.25 L multiscribe reverse transcriptase (50 U/ L). Reverse transcription was performed at

25°C for 10 min, 37°C for 60 min, and 95°C for 5 min, followed by quick chilling on ice, and stored at 20°C until subsequent amplification.

Quantitative real-time PCR analysis
Quantitative real-time polymerase chain reaction (PCR)
analysis was done as per the manufacturer’s instructions (Applied Biosystems, Foster City, CA) using TaqMan Gene Expression Assays. DNA amplification was carried out in 12.5
TaqMan Universal PCR Master Mix (AmpliTaq Gold DNA
polymerase, passive reference 1, buffer, dNTPs, AmpErase
UNG), 1 L cDNA, 9 L RNase-free water, and 1.25 L 18S
primer (VIC) and 1.25 L primer (FAM) (for endogenous reference and target cytokine) in a final volume of 25 L/well.
Human control RNA (calibrator RNA) was also used and served

TABLE 3. PLASMA CYTOKINE LEVELS IN 12 CYCLISTS UNDER CARBOHYDRATE (C)
AND PLACEBO (P) CONDITIONS BEFORE AND AFTER 2 H OF INTENSIVE CYCLING
Variable
IL-6 (pgmL1)
C
P
IL-8 (pgmL1)
C
P
IL-1Ra (pgmL1)
C
P
IL-10 (pgmL1)
C
P

Preexercise

Postexercise

1 h postexercise

p value:
interactionsa

1.28  0.68
0.56  0.23

14.6  2.44*
23.0  4.70

8.77  1.37*
12.6  2.66

0.007; 0.001

5.53  0.73
4.93  0.41

9.62  1.08
10.1  1.12

10.3  0.73
10.2  0.86

0.453; 0.001

202  56
184  22

323  63
374  54

624  275*
1215  503

0.010; 0.061

1.67  0.14
1.83  0.11

16.2  2.75*
25.3  4.32

16.5  4.06*
48.9  13.8

0.003; 0.001

aInteractions: The first p value represents the condition (carbohydrate vs. placebo)  time (3 time points) interaction; the second p value represents the overall time effect.
*Significant difference in change from preexercise in carbohydrate compared with placebo trials, p  0.05.
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as a calibrator for each plate. Samples were loaded in a MicroAmp 96-well reaction plate. Plates were run using the ABI
Sequence Detection System. After 2 min at 50°C and 10 min
at 95°C, plates were coamplified by 50 repeated cycles, of
which 1 cycle consisted of a 15-sec denaturing step at 95°C and
a 1-min annealing/extending step at 60°C. Data were analyzed
by ABI software using the cycle threshold (CT), which is the
value calculated and based on the time (measured by PCR cycle number) at which the reporter fluorescent emission increases
beyond a threshold level (based on the background fluorescence
of the system),28 and it reflects the cycle number at which the
cDNA amplification is first detected. We have previously reported detailed methodology concerning the dual amplification
technique.2,3,9 Samples were run in duplicate, and the intraassay and interassay CVs were determined to be 1.69% and 1.65%
for the CTs, respectively.

Calculations for relative quantification
Quantification of cytokine gene expression for IL-8, IL-10,
IL-1Ra, and IL-6 was calculated using the
CT method as described by Livak and Schmittgen.29 This method uses a single
sample, the calibrator sample, for comparison of every unknown
sample’s gene expression. This method of analysis and quantification has been shown to give similar results to the standard curve
method.28 Briefly, CT (CT(FAM)  CT(VIC)) was calculated
for each sample and calibrator.
CT ( CT(calibrator) 
CT(sample)) was then calculated for each sample, and relative
quantification was calculated as 2 CT. Initial exclusion criteria consisted of FAM CT 40 and VIC CT 23.

Hormones, glucose
Plasma concentrations of cortisol were determined using the
competitive solid-phase 125I radioimmunoassay (RIA) technique (Diagnostic Products Corporation, Los Angeles, CA) with
cortisol-specific antibody (Ab)-coated tubes (Coat-A-Count
tubes). Intraassay (CVintra) and interassay (CVinter) coeffi-
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FIG. 2. IL-1Ra mRNA expression in blood leukocytes from
cyclists during 2 h of cycling at 64% Wattsmax under carbohydrate and placebo conditions. Values are expressed as a fold
change from rest, with rest equal to 1. Time effect, p  0.003;
carbohydrate/placebo condition x time effect, p  0.634.
cients of variation were 4.5% and 5%, respectively. Assay sensitivity was 5.5 nmol/L (0.2 g/dL). RIA kits were also used to
determine plasma concentrations of insulin in duplicate according to the manufacturer’s instructions (Diagnostic Products
Corporation). CVintra and CVinter were 5% and 7%, respectively. Assay sensitivity was 1.2 g/dL. For plasma epinephrine, blood samples were drawn into chilled tubes containing
EGTA and glutathione and centrifuged, and the plasma was
stored at 80°C until analysis. Plasma concentrations of epinephrine were determined by competitive EIA (Labor Diagnostika Nord, Nordhorn, Germany) using the microtiter plate
format as described previously.2 The CVintra and CVinter variation were 11% and 14%, respectively. The sensitivity of this
assay for plasma samples is 11 pg/mL. Plasma glucose was analyzed spectrophotometrically using a glucose oxidase reagent
(Randox Laboratories Ltd., Belfast, Northern Ireland) in a microtiter plate-based assay.

Plasma cytokine measurements
Total plasma concentrations of IL-1Ra, IL-6, IL-8, and IL-10
were determined using quantitative sandwich ELISA kits provided
by R&D Systems, Inc. (Minneapolis, MN). All samples and provided standards were analyzed in duplicate. The minimum detectable concentrations were IL-1Ra 22 pg  mL1, IL-6 0.70
pg  mL1, IL-6 (high sensitivity) 0.094 pg  mL1, IL-8 10
pg  ml1, and IL-10 3.9 pg  mL1. A high sensitivity kit
was used to analyze IL-6 in the prerace plasma samples. Because of the lack of high-sensitivity kits for IL-8 and IL-10, we
extrapolated data below the minimum detectable level using a
software program suited to this task (SOFTmax, Molecular Devices, Sunnyvale, CA). Preexercise and postexercise samples
for IL-8, IL-10, and IL-1Ra were analyzed on the same assay
plate to decrease interkit assay variability.
FIG. 1. IL-10 mRNA expression in blood leukocytes from
cyclists during 2 h of cycling at 64% Wattsmax under carbohydrate and placebo conditions. Values are expressed as a fold
change from rest, with rest equal to 1. Time effect, p  0.001;
carbohydrate/placebo condition  time effect, p  0.220.

Statistical analysis
Values were expressed as mean  SE. Performance measures across the two exercise trials were compared using paired
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t-tests. Data in Tables 2 and 3 and all figures were analyzed using a 2 (carbohydrate and placebo conditions)  3 (times of
measurement) repeated-measures ANOVA. When Box’s M
suggested that the assumptions necessary for the univariate approach were not tenable, the multivariate approach to repeated
measures ANOVA was used (Pillais trace). If the interaction p
value was 0.05, the changes from preexercise to postexercise
values were calculated and compared using paired t-tests, with
statistical significance set at p  0.05.

RESULTS
Subject characteristics and results from the maximal cardiorespiratory tests for the 12 male cyclists are listed in Table
1. Three-day food records indicated no significant differences
in macronutrient intakes between test sessions, with a mean energy intake of 13.1  0.9 MJ  day1 (3119  213 kcal  day1)
and a percent of energy intake of 60.2%  2.6% carbohydrate,
27.5%  1.9% fat, and 14.4%  1.0% protein. Power output
and heart rate did not differ between the two test sessions, and
averaged 214  5 W (63.9  0.7% Wattsmax), 159  3 heart
beats/min (83.3  1.1% HRmax), and 73.6  1.5%VO2max.
Plasma glucose, insulin, cortisol, and epinephrine data are
summarized in Table 2. Significant condition (carbohydrate vs.
placebo)  time interaction effects were measured for each of
these variables. Postexercise levels of glucose were higher in
the carbohydrate than in the placebo trials (17% vs. 6.1%, respectively), and levels of cortisol (8.8% vs. 62%, respectively)
and epinephrine (-9.2% vs. 138%, respectively) were lower.
Plasma cytokine data are summarized in Table 3. Significant
condition  time interaction effects were measured for IL-6,
IL-1Ra, and IL-10 but not IL-8. In the carbohydrate compared
with placebo trials, lower plasma levels were measured for IL6 (10-fold vs. 40-fold, respectively, immediately postexercise),
IL-10 (8.9-fold vs. 26-fold, respectively, 1 h postexercise), and
IL-1Ra (2.1-fold vs. 5.6-fold, respectively, 1 h postexercise).

FIG. 4. IL-8 mRNA expression in blood leukocytes from cyclists during 2 h of cycling at 64% Wattsmax under carbohydrate and placebo conditions. Values are expressed as a fold
change from rest, with rest equal to 1. Time effect, p  0.003;
carbohydrate/placebo condition x time effect, p  0.397.

Figures 1, 2, 3, and 4 summarize the leukocyte mRNA data.
Leukocyte mRNA expression for IL-10 (Fig. 1), IL-1Ra (Fig.
2), and IL-8 (Fig. 4) increased postexercise (time effects, p 
0.001, 2.7-fold increase 1 h postexercise; p  0.003, 2.2-fold
increase; p  0.003, 2.4-fold increase, respectively), but the
pattern of change over time did not vary between the carbohydrate and placebo trials (p  0.220, p  0.634, p  0.397, respectively). Leukocyte mRNA expression for IL-6 (Fig. 3) decreased post-exercise (time effect, p  0.040, 0.8-fold decrease)
but did not differ by condition (p  0.817).
Mean CT values (combining preexercise and postexercise
values) for IL-8, IL-10, IL-1Ra, and IL-6 were 12.5  0.2,
21.6  0.2, 14.7  0.2, and 21.7  0.2, respectively.

DISCUSSION

FIG. 3. IL-6 mRNA expression in blood leukocytes from cyclists during 2 h of cycling at 64% Wattsmax under carbohydrate and placebo conditions. Values are expressed as a fold
change from rest, with rest equal to 1. Time effect, p  0.040;
carbohydrate/placebo condition  time effect, p  0.817.

We determined that leukocyte mRNA expression for IL-8,
IL-10, and IL-1Ra, but not for IL-6, increased postexercise to
a similar degree during the carbohydrate and placebo cycling
trials. Our data also indicate that exercise induced increases in
plasma cortisol, epinephrine, IL-6, IL-1Ra, and IL-10 were attenuated when cyclists ingested carbohydrate compared with
placebo beverages, confirming previously published findings
from our laboratory and others.1–3,5,9,19,25,26
This is the first study to show that heavy exercise workloads
increase mRNA content in blood leukocytes for IL-10, IL-1Ra,
and IL-8, but not IL-6, under both carbohydrate and placebo
conditions. The mechanisms involved in this disparity between
the IL-6 response and other cytokines remain unclear at this
time. Two other studies have shown that exercise does not induce IL-6 mRNA expression in blood mononuclear cells.10,14
The absolute abundance of IL-8, IL-1Ra, and IL-10 mRNA
from blood leukocytes in our subjects was high (i.e., low mean
CT values), indicating a substantial potential contribution to
plasma cytokine levels. For the same amount of total mRNA,
IL-8 and IL-10 mRNA abundance in blood leukocytes was well
above levels we have previously reported from muscle biopsy

EXERCISE AND BLOOD CYTOKINE mRNA
samples.2,9 IL-8 was approximately 1000-fold greater and IL10 was 128-fold greater in the leukocyte pellets compared with
the muscle biopsy samples.2 Despite the low numbers of leukocytes expected in postexercise muscle tissue, we propose that
part of the IL-8 mRNA expression in this tissue is from the
leukocytes.
The pattern of change in plasma IL-8 paralleled increases in
blood leukocyte IL-8 mRNA during both exercise trials, suggesting that gene expression and production and release of IL8 are regulated by factors related to exercise workload and not
hormonal influences altered by carbohydrate or placebo ingestion. Previous research has indicated that IL-8, a chemotactic
cytokine, is produced by multiple cell types, including endothelial cells, fat cells, mononuclear cells in blood, macrophages,
and cells in bone, skin, and muscle. 15 IL-8 is an important mediator of inflammatory disorders and stimulates polymorphonuclear cell adherence, degranulation, and respiratory burst
activity.15 IL-8 is rapidly induced by many stimuli including,
TNF-, IL-1, and bacterial agents, but whether these are important during exercise conditions is unknown.
Postexercise plasma levels of IL-1Ra, IL-10, and IL-6, however, did not parallel increases in blood leukocyte cytokine
mRNA expression during both exercise trials. These data indicate that postexercise plasma IL-1Ra, IL-10, and IL-6 levels
under carbohydrate/placebo conditions represent the cumulative effects of multiple factors that transpire following gene expression in several cell sources. Febbraio et al.,19 for example,
have shown that IL-6 release from the contracting muscle is decreased when subjects ingest carbohydrate compared with
placebo beverages despite similar increases in muscle IL-6
mRNA, and they reasoned that IL-6 release is regulated by substrate availability. Most studies have shown that cycling exercise induces short-lived but significant increases in muscle
mRNA for IL-6, IL-8, IL-1, and TNF-, and that increases
are similar under carbohydrate compared with placebo conditions despite lower plasma IL-6 levels.2,8,19,26 Thus, cytokine
mRNA expression in blood leukocyte or muscle biopsy samples or both does not necessarily correspond with cytokine release or plasma cytokine levels.
In summary, our most important finding is that gene expression for IL-8, IL-10, and IL-1Ra, but not IL-6, is increased
in blood leukocytes taken from athletes following 2 h of intensive cycling and is not influenced by carbohydrate compared
with placebo ingestion. mRNA expression was high enough to
indicate a substantial contribution of blood leukocytes to plasma
levels of IL-8, IL-10, and IL-1Ra during prolonged exercise.
Except for IL-8, however, postexercise plasma levels of these
cytokines did not parallel blood leukocyte mRNA expression
during each of the carbohydrate/placebo trials, indicating that
cytokine production and release are influenced by posttranscriptional events or that cytokines are being produced and released from other cell types.
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